HELIX BIOPHARMA CORP

Helix BioPharma is a biopharmaceutical company that specializes in developing an innovative oncology platform technology to target and destroy cancer cells by inducing an increase in tumor pH. Their patented dual-action approach aims to combat tumor acidity while restoring immunity, offering potential advancements in cancer treatment.

We use cookies to enhance your experience. By continuing to visit this site, you agree to our cookies policy